# Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

> **NCT01572545** · NA · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 91 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Zoledronic acid

## Key facts

- **NCT ID:** NCT01572545
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-09
- **Final completion:** 2013-01
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2013-01-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572545, "Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01572545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*